Cell culture detection of microvascular cell death in clinical specimens of human neoplasms and peripheral blood

Journal of Internal Medicine

Volumn 264, Issue 3, 2008, Pages 275-287

  Weisenthal, L M ^a   Patel, N ^a   Rueff Weisenthal, C ^a  

^a Weisenthal Cancer Group   (United States)

Author keywords

Angiogenesis; Cancer; Cancer chemotherapy; Cell biology; Endothelial cells; Oncology

Indexed keywords

ALCOHOL; BEVACIZUMAB; CISPLATIN; DIACETOXYSCIRPENOL; DIMETHYL SULFOXIDE; DOXORUBICIN; ERLOTINIB; FLUDARABINE; GEFITINIB; IMATINIB; RITUXIMAB; SORAFENIB; SUNITINIB; VASCULOTROPIN;

ADENOCARCINOMA; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD; BREAST CANCER; CARCINOID; CELL DEATH; CELL TYPE; COLON CANCER; COMPUTER PROGRAM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMAGE ANALYSIS; LUNG NON SMALL CELL CANCER; MESOTHELIOMA; MICROVASCULAR CELL; MICROVASCULATURE; NEOPLASM; NONHODGKIN LYMPHOMA; OVARY CANCER; PRIORITY JOURNAL; PROTEIN SECRETION; STAINING; TUMOR CELL;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DEATH; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPH NODES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 49349115989     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01955.x     Document Type: Article

References (14)

1. Bertolini F, Mancuso P, Shaked Y, Kerbel RS. Molecular and cellular biomarkers for angiogenesis in clinical oncology. Drug Discov Today 2007 12 :806 12.
2. Dong X, Han ZC, Yang R. Angiogenesis and antiangiogenic therapy in haematologic malignancies. Crit Rev Oncol Hematol. 2007 62 :105 118.
3. Bos CJ, Lip GY, Blann AD. Circulating endothelial cells in cardiovascular disease. J Am Coll Cardiol. 2006 48 :1538 1547. Epub 2006 Sep 26.
4. Goon PKY, Wilson T, Stonelake PS, Lip GYH. The quest for circulating endothelial cell standardization: the peril of platelets. Cytometry B: Clin Cytometry 2007 72B :416.
5. Weisenthal LM, Marsden JA, Dill PL, Macaluso CK. A novel dye exclusion method for testing in vitro sensitivitiy of human tumours. Cancer Res 1983 43 :749 57.
6. Weisenthal LM, Dill PL, Pearson FC. Effect of prior chemotherapy on human tumour-specific cytotoxicity in vitro in response to immunopotentiating biologic response modifiers. J Natl Cancer Inst 1991 83 :37 42.
7. De Youg BR, Frierson HF Jr., Ly MN, Smith D, Swanson PE. CD31 immunoreactivity in carcinomas and mesotheliomas. Am J Clin Pathol 1998 110 :374 7.
8. Verheul HMW, Lolkema MPJ, Qian DZ et al. Platelets take up the monoclonal antibody bevacizumab. Clin Cancer Res 2007 13 :5341 7.
9. Huang J, Frischer JS, Serur A et al. Regression of established tumours and metastases by potent vascular endothelial growth factor blockade. Proc Natl Acad Sci U S A 2003 100 :7785 90.
10. Lee YK, Shanafelt TD, Bone ND, Strenge AK, Jelinek DF, Kay NE. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance. Leukemia 2005 19 :513 23.
11. Eter N, Spitznas M. DMSO mimics inhibitory effect of thalidomide on choriocapillary endothelial cell proliferation in culture. Br J Ophthalmol 2002 86 :1303 5.
12. Radek KA, Matthies AM, Burns AL, Heinrich SA, Kovacs EJ, Dipietro LA. Acute ethanol exposure impairs angiogenesis and the proliferative phase of wound healing. Am J Physiol Heart Circ Physiol 2005 289 :H1084 90.
13. Eichbaum MHR, Schneeweiss A, Bastert G. Long term remission of excessive liver metastatasis in a breast cancer patient with chronic alcohol abuse using a monotherapy with trastuzamab. Anticancer Drugs 2005 16 :199 200.
14. Albanell J, Codony J, Rovira A, Mellado B, Gascon P. Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4. Adv Exp Med Biol 2003 532 :253 68.